Neopharma launches its four new products.

Neopharma launches its four new products.

Abu Dhabi based pharmaceutical manufacturer Neopharma has diversified into new segments with the launch of four new products to cater to the needs of the UAE as well enlarging exports market.
The company, known for introducing new products in quick succession, is focusing on strengthening its antibiotic portfolio, with key anti-biotics such as coamoxyclav, clarithromycin and ciprofloxacin already in the market, the introduction of cefuroxime axetil and doxycycline will witness the company’s foray into the cephalosporins and tetracycline antibiotics segments.

dd